Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations

Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations

Background: Treatment of patients with juvenile idiopathic arthritis (JIA) is one of the most complex and urgent problems of rheumatology.Objective: Our aim was to evaluate the efficacy and safety of adalimumab therapy combined with immunosuppressants in patients with JIA without systemic manifestat...

Full description

Bibliographic Details
Main Authors: E. I. Alexeeva, T. M. Bzarova, S. I. Valieva, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, T. V. Sleptsova, N. I. Taibulatov, A. N. Fetisova, M. Sh. Shingarova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2015-09-01
Series:Вопросы современной педиатрии
Subjects:
дети
ювенильный идиопатический артрит
адалимумаб
метотрексат
эффективность
безопасность
Online Access:https://vsp.spr-journal.ru/jour/article/view/1076

Internet

https://vsp.spr-journal.ru/jour/article/view/1076

Similar Items